PPD Inc. (PPD) Business Metric Overview - Stocknear

PPD Inc.

NASDAQ: PPD · Real-Time Price · USD
47.28
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

PPD Revenue Breakdown

Period Ending Sep 30, 2021
Clinical Development Services Segment Revenue 1.27B
Clinical Development Services Segment Revenue Growth n/a
Laboratory Services Segment Revenue 290.18M
Laboratory Services Segment Revenue Growth n/a

Revenue by Geography

Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Asia Revenue 145.66M 164.77M 131.83M 157.03M 124.98M 111.99M 114.86M
Asia Revenue Growth -11.60% +24.98% -16.04% +25.64% +11.60% -2.50% n/a
Emea Revenue 396.29M 51.64M 42.38M 48.67M 39.59M 45.71M 44.91M
Emea Revenue Growth +667.40% +21.86% -12.93% +22.93% -13.39% +1.78% n/a
Latin America Revenue 41.22M 967.64M 821.21M 776.15M 737.23M 574.06M 558.24M
Latin America Revenue Growth -95.74% +17.83% +5.81% +5.28% +28.42% +2.83% n/a
North America Revenue 977.63M n/a n/a n/a n/a n/a n/a
North America Revenue Growth n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018
Selling, General, and Administrative Revenue 335.62M 330.03M 293.94M 275.42M 249.32M 237.62M 314.09M 324.31M 293.88M 301.64M 283.8M 277.11M
Selling, General, and Administrative Revenue Growth +1.70% +12.28% +6.72% +10.47% +4.93% -24.35% -3.15% +10.35% -2.57% +6.29% +2.41% n/a
Research and Development Revenue n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a